
Want to see the real deal?
More inside scoop? View in App
More inside scoop? View in App
blind
SUPPORT
FOLLOW US
DOWNLOAD THE APP:
FOLLOWING
Industries
Job Groups
- Software Engineering
- Product Management
- Information Technology
- Data Science & Analytics
- Management Consulting
- Hardware Engineering
- Design
- Sales
- Security
- Investment Banking & Sell Side
- Marketing
- Private Equity & Buy Side
- Corporate Finance
- Supply Chain
- Business Development
- Human Resources
- Operations
- Legal
- Admin
- Customer Service
- Communications
Return to Office
Work From Home
COVID-19
Layoffs
Investments & Money
Work Visa
Housing
Referrals
Job Openings
Startups
Office Life
Mental Health
HR Issues
Blockchain & Crypto
Fitness & Nutrition
Travel
Health Care & Insurance
Tax
Hobbies & Entertainment
Working Parents
Food & Dining
IPO
Side Jobs
Show more
SUPPORT
FOLLOW US
DOWNLOAD THE APP:
PRA Health Sciences News

PRA Health Sciences Yahoo Finance / Apr 28, 2021

PRA Health Sciences Benzinga / Apr 28, 2021
Shares of PRA Health Sciences (NASDAQ: PRAH) fell after the company reported Q1 results. Earnings per share were up 28.57% year over year to $1.35, which beat the estimate of $1.34. Revenue of $933,775,000 higher by 19.15% from the same period last year, which beat the estimate of $860,060,000.

PRA Health Sciences CML News / Apr 28, 2021
PRA Health Sciences Inc (PRAH) - Pra Health Sciences, Inc. Reports First Quarter 2021 Results.Q1 GAAP Earnings per Share $0.86.Q1 Adjusted Earnings per Share $1.35.Q1 Revenue $933.8 Million.Q1 Earnings per Share View $1.34, Revenue View $860.1 Million -- Refinitiv Ibes Data (analyst estimates).

PRA Health Sciences Seeking Alpha / Apr 28, 2021
PRA Health Sciences (PRAH): Q1 Non-GAAP EPS of $1.35 beats by $0.02; GAAP EPS of $0.86 misses by $0.08.Revenue of $933.8M (+19.2% Y/Y) beats by $70.88M.Press Release
PRA Health Sciences EPS beats by $0.02, beats on revenue
Seeking Alpha

PRA Health Sciences Zacks.com / Apr 28, 2021
PRA Health Sciences ( - Free Report) came out with quarterly earnings of $1.35 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $1.05 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 0.75%.

PRA Health Sciences STAT / Apr 28, 2021
he Covid-19 pandemic has thrown into relief the long-standing racial inequities in the U.S. health care system. One major problem: making sure that the studies that test medical treatments reflect the populations of people who will receive them. In this virtual event, we'll talk about possible solutions.

PRA Health Sciences PRNewswire / Apr 28, 2021
NEW YORK, April 28, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: PRA Health Sciences Inc.

PRA Health Sciences STAT / Apr 28, 2021
he humble pipette tip is tiny, cheap, and utterly essential to science. It powers research into new medicines, Covid-19 diagnostics, and every blood test ever run. It is also, ordinarily, abundant - a typical bench scientist might grab dozens every day.

PRA Health Sciences KSU | The Sentinel Newspaper / Apr 28, 2021
2020-2025 Global Clinical Research Services Market Report - Production and Consumption Professional Analysis (Impact of COVID-19) , Covid 19 Outbreak Impact research report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

PRA Health Sciences The Courier / Apr 28, 2021
"On Clinical Research Services Market, Market Research Store published a report overview By Size, Industry leading Manufactures, Trends, Industry Growth Analysis & Forecast Till 2026" includes 190+ research pages PDF with TOC come up with a list of figures and tables. Market Research Store presents an latest and updated Study on Clinical Research Services Market 2021-2026.

PRA Health Sciences KSU | The Sentinel Newspaper / Apr 28, 2021
A new Research Report published by JCMR under the title Global Clinical Contract Research Services Market (COVID 19 Version) can grow into the world's most important market which has played an important role in making progressive impacts on the global economy.

PRA Health Sciences KSU | The Sentinel Newspaper / Apr 28, 2021
The global "U.S. Contract Research Organization (CROs) Market" research report highlights the need for up-to-date market data for the business management that will offer development and profitability of the global U.S. Contract Research Organization (CROs) market. The research report presents all the essential facts and figures on drifts & growths.

PRA Health Sciences KSU | The Sentinel Newspaper / Apr 28, 2021
Industrial Forecast on Global Bioanalytical Testing Services Market: The report comprises of a comprehensive analysis of the Global Bioanalytical Testing Services Market on the Global and Regional basis. Global Global Bioanalytical Testing Services Market is expected to register a strong CAGR in the Forecast Period 2021 to 2029.

PRA Health Sciences Yahoo Finance / Apr 28, 2021
Clinical Trial Supply & Logistics for Pharmaceutical Market Research Report by Phase (BA/BE Studies, Phase I, Phase II, Phase III, and Phase IV), by Sector (Clinical Trial Logistics and Distributions, Clinical Trial Manufacturing Services, and Clinical Trial Supply Chain Management), by Therapeutic Area - Global Forecast to 2025 - Cumulative

PRA Health Sciences The Courier / Apr 27, 2021
Home / Business /Global Healthcare Contract Research Organizations (CRO) Services Market Report- Top Manufactures, Size, Market Demands, Industry Growth Analysis| Pra Health Sciences, Syneos Health, Medpace, Wuxi Apptec, PPD Inc. Global Healthcare Contract Research Organizations (CRO) Services Market The insight Partners Research has recently added a concise research on the Global Healthcare Contract Research Organizations (CRO) Services Market - Industry Trends and Forecast to 2027.

PRA Health Sciences WTSP.com / Apr 27, 2021
Many people have found during the pandemic, not only did they need or want mental health counseling, they enjoyed doing it virtually. TAMPA, Fla. - While the pandemic has certainly taken a toll on mental health in this country, it has also created opportunities for more jobs.

PRA Health Sciences NeighborWebSJ / Apr 27, 2021
JCMR recently broadcasted a new study in its database that highlights the in-depth market analysis with future prospects of Outsourcing in Drug Development market. The study covers significant data which makes the research document a handy resource for managers, industry executives and other key people get ready-to-access and self analyzed study along with graphs and tables to help understand market trends, drivers and market challenges.

PRA Health Sciences SoccerNurds / Apr 27, 2021
Introduction: Global Biopharmaceutical CMO and CRO Market The detailed analysis of the global Biopharmaceutical CMO and CRO market and all the dynamics related to it is offered in research report. The research report on global Biopharmaceutical CMO and CRO market digs the study of all the major industrial events in recent years such as major investments, innovations, collaborations, mergers, development plans, strategies for the forecast period, etc.

PRA Health Sciences KSU | The Sentinel Newspaper / Apr 27, 2021
Contract Research Organizations Market Data and Acquisition Research Study with Trends and Opportunities 2019-2024 The study of Contract Research Organizations market is a compilation of the market of Contract Research Organizations broken down into its entirety on the basis of types, application, trends and opportunities, mergers and acquisitions, drivers and restraints, and a global outreach.

PRA Health Sciences GuruFocus.com / Apr 27, 2021
Camas, WA, based Investment company Fisher Asset Management, LLC ( Current Portfolio) buys iShares 7-10 Year Treasury Bond ETF, SPDR Portfolio Long Term Treasury ETF, Capital One Financial Corp, Unilever PLC, Sandvik AB, sells iShares MBS ETF, iShares iBoxx USD High Yield Corporate Bond ETF, Xtrackers USD High Yield Corporate Bond ETF, iShares Broad USD High Yield Corporate Bond ETF, Vanguard Mortgage-Backed Securities ETF during the 3-months ended 2021Q1, according to the most recent filings of the investment company, Fisher Asset Management, LLC.
Fisher Asset Management, LLC B
GuruFocus.com




STAT







